Stage I melanoma of the limbs. Immediate versus delayed node dissection

Area of Science:

• Oncology
• Surgical Oncology
• Dermatology

Background:

• Malignant melanoma is a significant public health concern.
• Optimal surgical management for stage I malignant melanoma of the limbs remains an area of investigation.

Purpose of the Study:

• To compare the survival outcomes of immediate versus delayed lymph node dissection in patients with stage I malignant melanoma of the limbs.
• To evaluate if specific patient or tumor characteristics influence the benefit of immediate lymph node dissection.

Main Methods:

• Prospective randomized clinical trial involving 553 patients with stage I malignant melanoma of the limbs.
• Comparison of wide excision with immediate node dissection versus wide excision with delayed node dissection.
• Subgroup analyses based on sex, tumor diameter, elevation, histologic type, Clark's level, and Breslow thickness.

Main Results:

• Overall survival was identical between the immediate and delayed node dissection groups.
• No significant survival benefit was observed with immediate node dissection in any evaluated subgroup, including by sex, tumor characteristics, or histologic type.
• Excisional biopsy prior to definitive treatment did not negatively impact survival.

Conclusions:

• Delayed lymph node dissection is as effective as immediate dissection for stage I malignant melanoma of the extremities.
• The findings suggest that immediate node dissection is not superior and may be unnecessary in this patient population.